Literature DB >> 31485743

Insights into the molecular features of the von Hippel-Lindau-like protein.

Giovanni Minervini1, Federica Quaglia1, Francesco Tabaro1,2, Silvio C E Tosatto3,4.   

Abstract

We present an in silico characterization of the von Hippel-Lindau-like protein (VLP), the only known human paralog of the von Hippel-Lindau tumor suppressor protein (pVHL). Phylogenetic investigation showed VLP to be mostly conserved in upper mammals and specifically expressed in brain and testis. Structural analysis and molecular dynamics simulations show VLP to be very similar to pVHL three-dimensional organization and binding dynamics. In particular, conservation of elements at the protein interfaces suggests VLP to be a functional pVHL homolog potentially possessing multiple functions beyond HIF-1α-dependent binding activity. Our findings show that VLP may share at least seven interactors with pVHL, suggesting novel functional roles for this understudied human protein. These may occur at precise hypoxia levels where functional overlap with pVHL may permit a finer modulation of pVHL functions.

Entities:  

Keywords:  Bioinformatics; Cancer; Hereditary neoplastic syndrome; Von Hippel–Lindau disease

Mesh:

Substances:

Year:  2019        PMID: 31485743     DOI: 10.1007/s00726-019-02781-8

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  2 in total

1.  Combined therapy guided by multimodal imaging of fifteen retinal capillary hemangioblastomas in a monocular Von Hippel- Lindau syndrome case report.

Authors:  Ju Guo; Liping Du; Pengyi Zhou; Xiaohong Guo; Fangfang Dai; Xuemin Jin
Journal:  BMC Ophthalmol       Date:  2022-05-06       Impact factor: 2.086

Review 2.  The emerging role of ubiquitin-specific protease 20 in tumorigenesis and cancer therapeutics.

Authors:  Qiong Li; Chanqi Ye; Tian Tian; Qi Jiang; Peng Zhao; Xiaoting Wang; Feiye Liu; Jianzhen Shan; Jian Ruan
Journal:  Cell Death Dis       Date:  2022-05-04       Impact factor: 9.685

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.